We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBX icon
226
Dropbox
DBX
$7.48B
$19.1M 0.09%
751,387
+9,078
+1% +$214K
BECN
227
DELISTED
Beacon Roofing Supply, Inc.
BECN
$19.1M 0.09%
220,953
-613
-0.3% -$54.6K
LMT icon
228
Lockheed Martin
LMT
$134B
$19M 0.09%
32,475
-275
-0.8% -$148K
MDLZ icon
229
Mondelez International
MDLZ
$80.2B
$18.9M 0.09%
256,726
-2,018
-0.8% -$142K
CATY icon
230
Cathay General Bancorp
CATY
$4.25B
$18.8M 0.09%
438,405
-5,438
-1% -$228K
CNC icon
231
Centene
CNC
$31.6B
$18.8M 0.09%
249,105
+8,316
+3% +$610K
DG icon
232
Dollar General
DG
$27.8B
$18.5M 0.09%
219,238
-13,317
-6% -$1.46M
MRVI icon
233
Maravai LifeSciences
MRVI
$1.01B
$18.5M 0.09%
2,226,034
-31,853
-1% -$275K
ZM icon
234
Zoom
ZM
$26.8B
$18.4M 0.09%
264,071
+13,513
+5% +$845K
GPK icon
235
Graphic Packaging
GPK
$3.45B
$18.3M 0.09%
619,010
-323,585
-34% -$9.21M
EQIX icon
236
Equinix
EQIX
$102B
$18.1M 0.09%
20,396
-3,925
-16% -$3.21M
HWC icon
237
Hancock Whitney
HWC
$6.19B
$18M 0.09%
350,959
-4,809
-1% -$245K
PRGS icon
238
Progress Software
PRGS
$1.66B
$17.9M 0.09%
265,474
-3,514
-1% -$201K
AMP icon
239
Ameriprise Financial
AMP
$48.3B
$17.9M 0.09%
38,000
-330
-0.9% -$143K
NKE icon
240
Nike
NKE
$63.9B
$17.7M 0.08%
200,078
-113,420
-36% -$8.89M
GE icon
241
GE Aerospace
GE
$377B
$17.7M 0.08%
93,751
+1,016
+1% +$172K
PDM
242
Piedmont Realty Trust
PDM
$1.2B
$17.7M 0.08%
1,748,563
-24,106
-1% -$215K
FFIV icon
243
F5
FFIV
$22.8B
$17.6M 0.08%
80,153
+7,136
+10% +$1.38M
BKU icon
244
Bankunited
BKU
$3.41B
$17.6M 0.08%
482,291
-6,749
-1% -$240K
AFL icon
245
Aflac
AFL
$65.9B
$17.5M 0.08%
156,742
-31,508
-17% -$3.2M
EFX icon
246
Equifax
EFX
$22B
$17.5M 0.08%
59,397
-9
-0% -$2.54K
MDY icon
247
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$17.4M 0.08%
30,632
+200
+0.7% +$110K
CWK icon
248
Cushman & Wakefield Ltd
CWK
$3.2B
$17.4M 0.08%
1,278,614
-17,419
-1% -$220K
RDN icon
249
Radian Group
RDN
$5.22B
$17.4M 0.08%
500,532
-6,003
-1% -$208K
SM icon
250
SM Energy
SM
$7.11B
$17.3M 0.08%
432,825
+10,728
+3% +$465K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.